Michael Stewart

CEO, CompanionDx

“The confluence of technology, health care needs and economics will allow patients to be in charge of a compilation of their personal health care data.”

Farideh Bischoff, Ph.D.

Executive Director of Scientific Affairs, Silicon Biosystems, Inc.

“Given that many new existing and future drugs target specific genomic sites in a tumor, the need to better understand the genetics of each person’s tumor is essential.”

Johnathan Lancaster, M.D., Ph.D.

Vice President, Medical Affairs, Myriad Genetic Labratories

“We are able to target cancer by matching a patient to a specific therapy based on the biology of his or her own tumor.”

Dr. Krister Wennerberg

FIMM-EMBL Group Leader and Head, High Throughput Biomedicine Unit, Institute for Molecular Medicine Finland (FIMM)

“Over the next decade, health care will increasingly involve personal genetic information together with disease stratification to provide individualized treatments with better outcomes and fewer side effects.”

Carl Morrison, DVM, M.D.

President, CSO, OmniSeq, LLC

“There are many benefits to the uptake of personalized medicine including tailoring treatments to individuals which not only improves outcomes but could help our health care system run in a more cost effective fashion.”